perindopril + indapamide + amlodipine + olmesartan + hydrochlorothiazide

This is a combination of five antihypertensive agents used for the management of high blood pressure. The components are: - Perindopril, an angiotensin-converting enzyme (ACE) inhibitor that lowers blood pressure by inhibiting the conversion of angiotensin I to angiotensin II, leading to vasodilation. - Indapamide, a thiazide-like diuretic that reduces blood volume and vascular resistance by promoting sodium and water excretion. - Amlodipine, a calcium channel blocker (CCB) that relaxes vascular smooth muscle and dilates arteries. - Olmesartan, an angiotensin II receptor blocker (ARB) that prevents vasoconstriction by blocking the action of angiotensin II on its receptor. - Hydrochlorothiazide, a thiazide diuretic with similar effects as indapamide. Each component targets different mechanisms involved in hypertension. Such combinations are used when monotherapy or dual therapy is insufficient for adequate blood pressure control. However, there is no evidence from available sources or clinical guidelines supporting the use or availability of this specific five-drug combination as a single product; rather, triple combinations such as perindopril/indapamide/amlodipine[1][2] and olmesartan/amlodipine/hydrochlorothiazide[3] exist separately.